This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Distretto Tecnologico Sicilia Micro E Nano Sistemi S.c.a.r.l.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Guido Ruggero Loria: Innovator in Nanoparticle Technology
Introduction
Guido Ruggero Loria is a prominent inventor based in Palermo, Italy. He has made significant contributions to the field of nanoparticle technology, particularly in the development of formulations for controlled drug release. His innovative work aims to enhance the treatment of various tumor diseases.
Latest Patents
Loria holds a patent for "Nanoparticles for controlled release of Sorafenib and Sorafenib derivatives." This patent describes loaded nanoparticles of Sorafenib, which are polymeric PBB nanoparticles. The formulation includes a method for obtaining these nanoparticles and their application in treating tumor diseases affecting the kidney, liver, thyroid, colon, breast, pancreas, lungs, and recurrent glioblastoma. He has 1 patent to his name.
Career Highlights
Loria is associated with the Distretto Tecnologico Sicilia Micro E Nano Sistemi S.c.a.r.l., where he continues to advance his research and development efforts. His work focuses on innovative solutions that leverage nanoparticle technology for medical applications.
Collaborations
Loria collaborates with notable colleagues such as Stefano Puleo and Antonina Azzolina. Their combined expertise contributes to the success of their projects and enhances the impact of their research.
Conclusion
Guido Ruggero Loria is a key figure in the field of nanoparticle technology, with a focus on improving cancer treatment through innovative drug delivery systems. His contributions are paving the way for advancements in medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile